| TRAIL‐R2: a novel apoptosis‐mediating receptor for TRAIL H Walczak, MA Degli‐Esposti, RS Johnson, PJ Smolak, JY Waugh, ... The EMBO journal, 1997 | 1482 | 1997 |
| The novel receptor TRAIL-R4 induces NF-κB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain MA Degli-Esposti, WC Dougall, PJ Smolak, JY Waugh, CA Smith, ... Immunity 7 (6), 813-820, 1997 | 1113 | 1997 |
| Activation of NK cell cytotoxicity MJ Smyth, E Cretney, JM Kelly, JA Westwood, SEA Street, H Yagita, ... Molecular immunology 42 (4), 501-510, 2005 | 980 | 2005 |
| Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family MA Degli-Esposti, PJ Smolak, H Walczak, J Waugh, CP Huang, ... The Journal of experimental medicine 186 (7), 1165, 1997 | 867 | 1997 |
| Close encounters of different kinds: dendritic cells and NK cells take centre stage MA Degli-Esposti, MJ Smyth Nature Reviews Immunology 5 (2), 112-124, 2005 | 761 | 2005 |
| Functional interactions between dendritic cells and NK cells during viral infection DM Andrews, AA Scalzo, WM Yokoyama, MJ Smyth, MA Degli-Esposti Nature immunology 4 (2), 175-181, 2003 | 457 | 2003 |
| ILC1 confer early host protection at initial sites of viral infection OE Weizman, NM Adams, IS Schuster, C Krishna, Y Pritykin, C Lau, ... Cell 171 (4), 795-808. e12, 2017 | 405 | 2017 |
| NK cell maturation and peripheral homeostasis is associated with KLRG1 up-regulation ND Huntington, H Tabarias, K Fairfax, J Brady, Y Hayakawa, ... the Journal of Immunology 178 (8), 4764-4770, 2007 | 359 | 2007 |
| Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity CE Andoniou, SLH van Dommelen, V Voigt, DM Andrews, G Brizard, ... Nature immunology 6 (10), 1011-1019, 2005 | 352 | 2005 |
| Infection of dendritic cells by murine cytomegalovirus induces functional paralysis DM Andrews, CE Andoniou, F Granucci, P Ricciardi-Castagnoli, ... nature immunology 2 (11), 1077-1084, 2001 | 346 | 2001 |
| CIS is a potent checkpoint in NK cell–mediated tumor immunity RB Delconte, TB Kolesnik, LF Dagley, J Rautela, W Shi, EM Putz, ... Nature immunology 17 (7), 816-824, 2016 | 345 | 2016 |
| A2AR adenosine signaling suppresses natural killer cell maturation in the tumor microenvironment A Young, SF Ngiow, Y Gao, AM Patch, DS Barkauskas, M Messaoudene, ... Cancer research 78 (4), 1003-1016, 2018 | 313 | 2018 |
| Interleukin 15–mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1 ND Huntington, H Puthalakath, P Gunn, E Naik, EM Michalak, MJ Smyth, ... Nature immunology 8 (8), 856-863, 2007 | 301 | 2007 |
| Ancestral haplotypes: conserved population MHC haplotypes MA Degli-Esposti, AL Leaver, FT Christiansen, CS Witt, LJ Abraham, ... Human immunology 34 (4), 242-252, 1992 | 287 | 1992 |
| A contribution of mouse dendritic cell–derived IL-2 for NK cell activation F Granucci, I Zanoni, N Pavelka, SLH Van Dommelen, CE Andoniou, ... The Journal of experimental medicine 200 (3), 287, 2004 | 277 | 2004 |
| β‐glucan triggers spondylarthritis and Crohn's disease–like ileitis in SKG mice M Ruutu, G Thomas, R Steck, MA Degli‐Esposti, MS Zinkernagel, ... Arthritis & rheumatism 64 (7), 2211-2222, 2012 | 263 | 2012 |
| Innate immunity defines the capacity of antiviral T cells to limit persistent infection DM Andrews, MJ Estcourt, CE Andoniou, ME Wikstrom, A Khong, V Voigt, ... The Journal of experimental medicine 207 (6), 1333, 2010 | 262 | 2010 |
| Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells V Voigt, CA Forbes, JN Tonkin, MA Degli-Esposti, HRC Smith, ... Proceedings of the National Academy of Sciences 100 (23), 13483-13488, 2003 | 235 | 2003 |
| CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10–driven MARCH1-mediated ubiquitination and degradation LE Tze, K Horikawa, H Domaschenz, DR Howard, CM Roots, RJ Rigby, ... The Journal of experimental medicine 208 (1), 149, 2011 | 234 | 2011 |
| To die or not to die—the quest of the TRAIL receptors M Degli-Esposti Journal of leukocyte biology 65 (5), 535-542, 1999 | 219 | 1999 |
